MCM
AGN

Manchester Capital Management’s Allergan Inc AGN Stock Holding History

Manchester Capital Management’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q1 		– Sell
-1,705
Closed -$362K – 1118
2014
Q4 		$362K Sell
1,705
-72
-4% -$14.3K 0.04% 226
2014
Q3 		$317K Hold
1,777
– – 0.04% 235
2014
Q2 		$301K Hold
1,777
– – 0.04% 271
2014
Q1 		$221K Buy
+1,777
New +$216K 0.04% 319
2013
Q4 		– Sell
-1,953
Closed -$177K – 1011
2013
Q3 		$177K Sell
1,953
-189
-9% -$17K 0.03% 355
2013
Q2 		$180K Buy
+2,142
New +$222K 0.03% 332

Other funds holding AGN

California Public Employees Retirement System
California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return
CA
Commerzbank Aktiengesellschaft Frankfurt, Germany $4.78B AUM 25.31% 1-Year Est. Return
ECM
Everence Capital Management Goshen, Indiana $1.64B AUM 26.46% 1-Year Est. Return
HFS
HL Financial Services Louisville, Kentucky $6.5B AUM 9.56% 1-Year Est. Return
AIM
Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Manchester Capital Management's AGN Position: Q1 2015 in Review

Manchester Capital Management sold out of Allergan Inc (AGN) in Q1 2015, closing a stake of 1,705 shares — an estimated $362K sold.

Manchester Capital Management first reported a position in AGN in Q2 2013 and held it in 6 quarters. The position peaked at $362K in Q4 2014. 5 funds tracked by Wall St. Rank hold AGN as of Q1 2015.

  • Manchester Capital Management reported no remaining Allergan Inc position as of Q1 2015 after selling out during the quarter.
  • Manchester Capital Management sold 1,705 Allergan Inc shares in Q1 2015, an estimated $362K.
  • Manchester Capital Management first reported a position in Allergan Inc in Q2 2013 and held it in 6 quarters.
  • Manchester Capital Management's Allergan Inc position peaked at $362K in Q4 2014.
  • 5 funds tracked by Wall St. Rank held Allergan Inc as of Q1 2015.

Based on Manchester Capital Management's 13F filing for Q1 2015, filed 7 May 2015.